EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardioplegia Strategies in Aortic Stenosis: A Focused Review of Current Evidence for Surgical Considerations

Minji Ho iD, Benjamin Chapman iD, Gianluca Lucchese iD, Paolo Bosco

Reviews in Cardiovascular Medicine · 14.10.2026 · 27 (10)

DOI: 10.31083/rcm52775 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 14.10.2026. Verfasst von Minji Ho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, St Thomas' Hospital, SE1 7EH London, UK. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe aortic stenosis (AS) exposes the hypertrophied myocardium to cardioplegic arrest in the setting of increased left ventricle (LV) mass, interstitial fibrosis, impaired relaxation, coronary microvascular dysfunction, and reduced perfusion reserve. These abnormalities may increase susceptibility to ischemic injury and complicate homogeneous cardioplegic delivery. This focused narrative review synthesizes physiological and clinical evidence on cardioplegia composition, temperature, delivery route, dosing, redosing, and myocardial protection during prolonged aortic cross-clamping in adults undergoing surgical aortic valve replacement. AS-specific comparative studies remain limited, generally small, and frequently reliant on biochemical markers; meanwhile, larger observational cohorts and contemporary randomized aortic valve replacement (AVR) trials also vary substantially in patient selection and myocardial protection protocols. Although some studies have associated cold blood cardioplegia with lower biomarker release than cold crystalloid cardioplegia, and cold maintenance strategies with less biochemical injury than warm cardioplegia, no formulation, temperature, or delivery route has demonstrated consistent superiority in clinically important outcomes. Limited historical evidence also suggests that body weight-based dosing may inadequately reflect myocardial requirements in marked LV hypertrophy, but no validated LV mass-based regimen currently exists. Therefore, cardioplegia in severe AS should be considered within a comprehensive myocardial protection protocol incorporating composition, temperature, dose, delivery route, redosing strategy, myocardial phenotype, associated valve or coronary disease, and anticipated cross-clamp duration. Prospective AS-specific studies using standardized protocols, LV mass stratification, and clinically meaningful outcomes are required.

Schlagwörter

Stichwörter der Autor:innen

aortic valve stenosiscardioplegic solutionscoronary circulationheart arrest, inducedheart valve prosthesis implantationhypertrophy, left ventricularhypothermia, inducedmyocardial reperfusion injury

Autor:innen und Institutionen

  • Department of Cardiac Surgery, St Thomas' Hospital, SE1 7EH London, UK.
  • Department of Physiology, Anatomy, and Genetics, University of Oxford, OX1 3PT Oxford, UK.

ORCID-Profile: Minji Ho, Benjamin Chapman, Gianluca Lucchese

Zitieren

APA

Ho, M., Chapman, B., Lucchese, G., & Bosco, P. (2026). Cardioplegia Strategies in Aortic Stenosis: A Focused Review of Current Evidence for Surgical Considerations. Reviews in Cardiovascular Medicine, 27(10). https://doi.org/10.31083/rcm52775

Vancouver

Ho M, Chapman B, Lucchese G, Bosco P. Cardioplegia Strategies in Aortic Stenosis: A Focused Review of Current Evidence for Surgical Considerations. Reviews in Cardiovascular Medicine. 2026;27(10). doi:10.31083/rcm52775

BibTeX
@article{Ho2026,
  author = {Ho, Minji and Chapman, Benjamin and Lucchese, Gianluca and Bosco, Paolo},
  title = {Cardioplegia Strategies in Aortic Stenosis: A Focused Review of Current Evidence for Surgical Considerations},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {10},
  doi = {10.31083/rcm52775}
}
Kostenlos starten →